Next Generation News and Research

RSS

Clinical data of CU-201, CUDC-101 presented at EORTC-NCI-AACR Symposium

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of data in two poster presentations at the 22nd EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics," held in Berlin, Germany, November 16-19.

19 Nov 2010

NTU to develop Five Peaks of Excellence under 5-year strategic plan

Nanyang Technological University (NTU) today unveiled NTU 2015, a five-year strategic plan that maps out how the university will become a great global university by 2015. Under this blueprint, NTU will build on its current strengths and heritage to make its mark globally in sustainability, healthcare, new media, the best of the East and West, and innovation.

18 Nov 2010

Neuralstem files NSI-189 IND with FDA for Phase I safety trials for major depression

Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin two Phase I safety trials to test NSI-189, its first small molecule compound, for the treatment of major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression.

18 Nov 2010

Siemens launches MAMMOMAT Inspiration Full-Field Digital Mammography System in the U.S.

Siemens announces that the MAMMOMAT® Inspiration Full-Field Digital Mammography System is now commercially available in the United States. The MAMMOMAT Inspiration offers digital screening and diagnostic mammography, stereotactic biopsy, and upgrade capability to future technologies all in one system.

17 Nov 2010

Aeterna Zentaris presents results of orally active compounds with anti-tumor effects at EORTC-NCI-AACR Symposium

Aeterna Zentaris Inc. today presented posters on encouraging preclinical results for AEZS-129 and AEZS-132, two novel orally active compounds with anti-tumor effects.

17 Nov 2010

Cardio3 BioSciences announces positive results from C-Cure Phase II clinical trial for heart failure

The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.

17 Nov 2010

Agilent introduces OpenLAB chromatography data system

Agilent Technologies Inc. today introduced Agilent OpenLAB CDS, the next-generation chromatography data system (CDS) of Agilent's market-leading ChemStation and EZChrom Elite CDS platforms. OpenLAB CDS is designed on the modern and fully scalable OpenLAB Shared Services architecture. This provides major feature improvements to current ChemStation and EZChrom Elite platforms.

17 Nov 2010

HCI unveils next-generation technology platform for fraud, waste, and abuse prevention and detection

HealthCare Insight (HCI) today unveiled Nucleus™, a next-generation technology platform for fraud, waste, and abuse prevention and detection, at the Annual Training Conference & Anti-Fraud Expo of the National Healthcare Anti-Fraud Association (NHCAA). The Nucleus application features advanced analytics, comprehensive risk scoring, and a customizable interface to help insurers stop fraud before medical claims are paid.

17 Nov 2010

Alkermes's ALKS 33 drug candidate offers potential treatment for multiple disease indications

Alkermes, Inc. today announced the presentation of promising preclinical results for its proprietary opioid modulator, ALKS 33, showing the drug candidate's potential in multiple disease indications.

17 Nov 2010

MLL purchases Access Array, EP1 Systems for high-throughput deep-resequencing analysis

Fluidigm Corporation announced today that MLL Munich Leukemia Laboratory has purchased Access Array and EP1 Systems. The Access Array System is being used in combination with Roche's 454 GS FLX and GS Junior sequencing instruments, enabling high-throughput targeted deep-resequencing analyses.

16 Nov 2010

New 3M Littmann auscultation device can transfer digitally captured patient sounds

With new technology announced today by 3M, a doctor in Minnesota can in real-time detect a murmur in the heart of a child in rural Arizona. Through the new 3M Littmann Scope-to-Scope Tele-Auscultation System, clinicians can transfer digitally captured patient sounds in real-time, from one stethoscope to another, no matter the distance.

16 Nov 2010

FDA announces program to facilitate development of external defibrillators to treat abnormal heart rhythms

The U.S. Food and Drug Administration today announced a program aimed at facilitating the development of safer, more effective external defibrillators used to treat abnormal heart rhythms through improved design and manufacturing practices. External defibrillators are medical devices designed to diagnose life-threatening abnormal heart rhythms and treat them by delivering electrical energy to the heart to restore its normal rhythm.

16 Nov 2010

Sonova 2010/11 first half sales increases 17.2% to CHF 832 million

Sonova generated a new sales record of CHF 832 million in the first half of 2010/11, an increase of 17.2% in Swiss francs compared to the previous year.

16 Nov 2010

WaferGen third quarter revenue increases to $633,000

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today reported financial results for the three and nine months ended September 30, 2010.

15 Nov 2010

RXi third quarter net loss increases to $4.1 million

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today reported its financial results for the third quarter ended September 30, 2010.

15 Nov 2010

GenturaDx to showcase IDbox molecular diagnostic system at AMP 2010

GenturaDx will display its proprietary molecular diagnostic system, the IDbox System, at the annual meeting of the Association for Molecular Pathology (AMP) in San Jose, Calif. on November 17 – 20, 2010. The IDbox System incorporates all aspects of its proprietary, real-time PCR testing from sample preparation through result generation in a single-use cassette.

15 Nov 2010

New AccuDetect software reduces false-positive rates during mammography screening

Parascript, LLC, the image analysis and pattern recognition technology provider, today announced the release of AccuDetect 4.0, the next generation of its computer-aided detection (CAD) software with significant performance improvements and a greater potential for lowering false-positive rates when detecting suspicious lesions on mammograms, compared to the previous version of the product.

15 Nov 2010

Spontaneous mutations can cause mental retardation

Dutch geneticists affiliated with the Radboud University Nijmegen Medical Centre present as a novel research paradigm that spontaneous mutations are an important cause of mental retardation.

15 Nov 2010

30 seconds to predict possibility of Alzheimer’s disease

It could take a mere 30 seconds to spot signs of Alzheimer’s disease in 40 year-olds in the near future say scientists who are developing a new diagnostic test. Usually Alzheimer’s disease is detected much later in life after the symptoms begin to appear.

14 Nov 2010

Bioethics in pharmaceutical industry, regenerative medicine, and public health

To celebrate 40 years of pioneering bioethics publication, the Hastings Center Report, the world's first bioethics journal, looked to the future, asking young scholars to write about what the next generation of bioethicists should take up. Out of 195 compelling submissions, four of the best essays were selected for publication in the November-December issue.

12 Nov 2010

Next Generation News and Research

Clinical data of CU-201, CUDC-101 presented at EORTC-NCI-AACR Symposium

NTU to develop Five Peaks of Excellence under 5-year strategic plan

Neuralstem files NSI-189 IND with FDA for Phase I safety trials for major depression

Siemens launches MAMMOMAT Inspiration Full-Field Digital Mammography System in the U.S.

Aeterna Zentaris presents results of orally active compounds with anti-tumor effects at EORTC-NCI-AACR Symposium

Cardio3 BioSciences announces positive results from C-Cure Phase II clinical trial for heart failure

Agilent introduces OpenLAB chromatography data system

HCI unveils next-generation technology platform for fraud, waste, and abuse prevention and detection

Alkermes's ALKS 33 drug candidate offers potential treatment for multiple disease indications

MLL purchases Access Array, EP1 Systems for high-throughput deep-resequencing analysis

New 3M Littmann auscultation device can transfer digitally captured patient sounds

FDA announces program to facilitate development of external defibrillators to treat abnormal heart rhythms

Sonova 2010/11 first half sales increases 17.2% to CHF 832 million

WaferGen third quarter revenue increases to $633,000

RXi third quarter net loss increases to $4.1 million

GenturaDx to showcase IDbox molecular diagnostic system at AMP 2010

New AccuDetect software reduces false-positive rates during mammography screening

Spontaneous mutations can cause mental retardation

30 seconds to predict possibility of Alzheimer’s disease

Bioethics in pharmaceutical industry, regenerative medicine, and public health

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News